ANGO

AngioDynamics Inc. (NASDAQ: ANGO) Q3 2021 earnings call dated Mar. 30, 2021. Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen…

AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A.…

AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen…

AngioDynamics Inc. (NASDAQ: ANGO) Q1 2021 earnings call dated Sep. 29, 2020 Corporate Participants: Jim Clemmer — President and Chief Executive Officer…

AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today. Net sales increased 6.3% to $70.2 million but were…

AngioDynamics, Inc. (NASDAQ: ANGO) Q4 2020 earnings call dated July 16, 2020 Corporate Participants: Jim Clemmer — President and Chief Executive Officer…

AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020. Net loss…

AngioDynamics Inc  (ANGO) Q2 2020 earnings call dated Jan. 07, 2020 Corporate Participants: Jim Clemmer — President, Chief Executive Officer, Director Steve…

— AngioDynamics Inc. (NASDAQ: ANGO) reported Q2 2020 earnings of $0.06 per share, vs. $0.02 expected. — Net sales remained…